ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 43 filers reported holding ATYR PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.19 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 4,626,624 | $7,310,066 | 2.43% |
| Tikvah Management LLC | 2,460,833 | $3,888,116 | 1.40% |
| TANG CAPITAL MANAGEMENT LLC | 471,134 | $744,392 | 0.10% |
| FEDERATED HERMES, INC. | 10,169,600 | $16,067,968 | 0.04% |
| Alyeska Investment Group, L.P. | 2,455,555 | $3,879,777 | 0.03% |
| XTX Topco Ltd | 73,894 | $116,753 | 0.02% |
| ALTERNA WEALTH MANAGEMENT, INC | 10,000 | $15,800 | 0.02% |
| Pale Fire Capital SE | 55,857 | $88,254 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 27,559 | $44 | 0.00% |
| Virtu Financial LLC | 13,662 | $22 | 0.00% |
| Man Group plc | 421,346 | $665,727 | 0.00% |
| Squarepoint Ops LLC | 139,990 | $221,184 | 0.00% |
| PFS Partners, LLC | 400 | $632 | 0.00% |
| Citadel Advisors | 1,784,136 | $2,818,935 | 0.00% |
| FMR LLC | 8,556,925 | $13,519,941 | 0.00% |
| TWO SIGMA ADVISERS, LP | 189,250 | $299,015 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 36,000 | $56,880 | 0.00% |
| Renaissance Technologies | 505,993 | $799 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,875 | $2,963 | 0.00% |
| NORTHERN TRUST CORP | 78,519 | $124,060 | 0.00% |
External links
This page lists ATYR PHARMA INC's shareholders in Q3 2023. To view ATYR PHARMA INC's shareholder history, click here.